# Collegium Pharmaceutical, Inc: Form 8-K, filed May 15, 2026

- Company: [Collegium Pharmaceutical, Inc](/companies/coll.md) (CIK 1267565)
- Form: 8-K
- Filed: 2026-05-15
- Accepted by EDGAR: May 15, 2026, 16:10 ET
- Period: 2026-05-14
- Accession: 0001104659-26-062536
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1267565/000110465926062536/tm2614189d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1267565/000110465926062536/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1267565/000110465926062536/tm2614189d1_8k.htm

Filed May 15, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-062536. Last ingested by Listed: Oct 29, 2026, 10:36 ET. No prices; not investment advice.